Literature DB >> 31395667

The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells.

Peder R Braadland1,2, Håkon Ramberg1, Helene Hartvedt Grytli1, Alfonso Urbanucci1,3,4, Heidi Kristin Nielsen1,2, Ingrid Jenny Guldvik1, Andreas Engedal1, Kirsi Ketola5, Wanzhong Wang6, Aud Svindland2,7, Ian G Mills3,8,9, Anders Bjartell10,11, Kristin Austlid Taskén12,2.   

Abstract

The incidence of treatment-related neuroendocrine prostate cancer (t-NEPC) is rising as more potent drugs targeting the androgen signaling axis are clinically implemented. Neuroendocrine transdifferentiation (NEtD), an putative initial step in t-NEPC development, is induced by androgen-deprivation therapy (ADT) or anti-androgens, and by activation of the β2-adrenergic receptor (ADRB2) in prostate cancer cell lines. Thus, understanding whether ADRB2 is involved in ADT-initiated NEtD may assist in developing treatment strategies that can prevent or reverse t-NEPC emergence, thereby prolonging therapeutic responses. Here we found that in primary, treatment-naïve prostate cancers, ADRB2 mRNA was positively correlated with expression of luminal differentiation markers, and ADRB2 protein levels were inversely correlated with Gleason grade. ADRB2 mRNA was upregulated in metastatic prostate cancer, and progressively downregulated during ADT and t-NEPC emergence. In androgen-deprivated medium, high ADRB2 was required for LNCaP cells to undergo NEtD, measured as increased neurite outgrowth and expression of neuron differentiation and neuroendocrine genes. ADRB2 overexpression induced a neuroendocrine-like morphology in both androgen receptor (AR)-positive and -negative prostate cancer cell lines. ADRB2 downregulation in LNCaP cells increased canonical Wnt signaling, and GSK3α/β inhibition reduced the expression of neuron differentiation and neuroendocrine genes. In LNCaP xenografts, more pronounced castration-induced NEtD was observed in tumors derived from high than low ADRB2 cells. In conclusion, high ADRB2 expression is required for ADT-induced NEtD, characterized by ADRB2 downregulation and t-NEPC emergence. IMPLICATIONS: This data suggest a potential application of β-blockers to prevent cancer cells committed to a neuroendocrine lineage from evolving into t-NEPC. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31395667     DOI: 10.1158/1541-7786.MCR-18-0605

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

1.  High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice.

Authors:  Riikka Huhtaniemi; Petra Sipilä; Arttu Junnila; Riikka Oksala; Matias Knuuttila; Arfa Mehmood; Eija Aho; Teemu D Laajala; Tero Aittokallio; Asta Laiho; Laura Elo; Claes Ohlsson; Malin Hagberg Thulin; Pekka Kallio; Sari Mäkelä; Mika V J Mustonen; Matti Poutanen
Journal:  iScience       Date:  2022-04-25

2.  Identify potential miRNA-mRNA regulatory networks contributing to high-risk neuroblastoma.

Authors:  Feng-Ling Shao; Qing-Qing Liu; Shan Wang
Journal:  Invest New Drugs       Date:  2021-03-05       Impact factor: 3.850

3.  Implication of β2-adrenergic receptor and miR-196a correlation in neurite outgrowth of LNCaP prostate cancer cells.

Authors:  Ilaria Guerriero; Håkon Ramberg; Krizia Sagini; Manuel Ramirez-Garrastacho; Kristin A Taskén; Alicia Llorente
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

4.  A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors).

Authors:  Sarah N Mapelli; Domenico Albino; Maurizia Mello-Grand; Dheeraj Shinde; Manuel Scimeca; Rita Bonfiglio; Elena Bonanno; Giovanna Chiorino; Ramon Garcia-Escudero; Carlo V Catapano; Giuseppina M Carbone
Journal:  Cancers (Basel)       Date:  2020-01-10       Impact factor: 6.639

Review 5.  Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression.

Authors:  Roosa Kaarijärvi; Heidi Kaljunen; Kirsi Ketola
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

6.  Neural regulations of the tumor microenvironment.

Authors:  Anthony C Restaino; Paola D Vermeer
Journal:  FASEB Bioadv       Date:  2021-09-12

7.  Sympathetic signaling facilitates progression of neuroendocrine prostate cancer.

Authors:  Shubham Dwivedi; Maricris Bautista; Sanskriti Shrestha; Hussain Elhasasna; Tanaya Chaphekar; Frederick S Vizeacoumar; Anand Krishnan
Journal:  Cell Death Discov       Date:  2021-11-22

Review 8.  Prostate gland as a target organ of thyroid hormones: advances and controversies.

Authors:  Brenda Anguiano; Carlos Montes de Oca; Evangelina Delgado-González; Carmen Aceves
Journal:  Endocr Connect       Date:  2022-02-14       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.